CDK9 phosphorylates RUNX1 to promote megakaryocytic fate in megakaryocytic-erythroid progenitors

2.

Xavier-Ferrucio

J

,

Krause

DS

.

Concise review: bipotent megakaryocytic-erythroid progenitors: concepts and controversies

.

STEM CELLS

.

2018

;

36

(

8

):

1138

-

1145

.

3.

Sanada

C

,

Xavier-Ferrucio

J

,

Lu

Y-C

, et al.

Adult human megakaryocyte-erythroid progenitors are in the CD34⁺CD38mid fraction

.

Blood

.

2016

;

128

(

7

):

923

-

933

.

4.

Kwon

N

,

Thompson

EN

,

Mayday

MY

,

Scanlon

V

,

Lu

YC

,

Krause

DS

.

Current understanding of human megakaryocytic-erythroid progenitors and their fate determinants

.

Curr Opin Hematol

.

2021

;

28

(

1

):

28

-

35

.

5.

Lu

YC

,

Xavier-Ferrucio

J

,

Wang

L

, et al.

The molecular signature of megakaryocyte-erythroid progenitors reveals a role for the cell cycle in fate specification

.

Cell Rep

.

2018

;

25

(

8

):

2083

-

2093.e2084

.

6.

Xavier-Ferrucio

J

,

Scanlon

V

,

Li

X

, et al.

Low iron promotes megakaryocytic commitment of megakaryocytic-erythroid progenitors in humans and mice

.

Blood

.

2019

;

134

(

18

):

1547

-

1557

.

7.

Warren

AJ

,

Bravo

J

,

Williams

RL

,

Rabbitts

TH

.

Structural basis for the heterodimeric interaction between the acute leukaemia-associated transcription factors AML1 and CBFb

.

EMBO J

.

2000

;

19

(

12

):

3004

-

3015

.

8.

Collins

A

,

Littman

DR

,

Taniuchi

I

.

RUNX proteins in transcription factor networks that regulate T-cell lineage choice

.

Nat Rev Immunol

.

2009

;

9

(

2

):

106

-

115

.

9.

Growney

JD

,

Shigematsu

H

,

Li

Z

, et al.

Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype

.

Blood

.

2005

;

106

(

2

):

494

-

504

.

10.

Owen

CJ

,

Toze

CL

,

Koochin

A

, et al.

Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy

.

Blood

.

2008

;

112

(

12

):

4639

-

4645

.

11.

Kuvardina

ON

,

Herglotz

J

,

Kolodziej

S

, et al.

RUNX1 represses the erythroid gene expression program during megakaryocytic differentiation

.

Blood

.

2015

;

125

(

23

):

3570

-

3579

.

12.

Zhou

L

,

Wu

D

,

Zhou

Y

, et al.

Tumor cell-released kynurenine biases MEP differentiation into megakaryocytes in individuals with cancer by activating AhR-RUNX1

.

Nat Immunol

.

2023

;

24

(

12

):

2042

-

2052

.

13.

Biggs

JR

,

Peterson

LF

,

Zhang

Y

,

Kraft

AS

,

Zhang

D-E

.

AML1/RUNX1 phosphorylation by cyclin-dependent kinases regulates the degradation of AML1/RUNX1 by the anaphase-promoting complex

.

Mol Cell Biol

.

2006

;

26

(

20

):

7420

-

7429

.

14.

Illendula

A

,

Gilmour

J

,

Grembecka

J

, et al.

Small molecule inhibitor of CBFβ-RUNX binding for RUNX transcription factor driven cancers

.

EBioMedicine

.

2016

;

8

:

117

-

131

.

15.

Zhang

L

,

Fried

FB

,

Guo

H

,

Friedman

AD

.

Cyclin-dependent kinase phosphorylation of RUNX1/AML1 on 3 sites increases transactivation potency and stimulates cell proliferation

.

Blood

.

2008

;

111

(

3

):

1193

-

1200

.

16.

Skene

PJ

,

Henikoff

S

.

An efficient targeted nuclease strategy for high-resolution mapping of DNA binding sites

.

Elife

.

2017

;

6

:

e21856

.

17.

Xie

Z

,

Bailey

A

,

Kuleshov

MV

, et al.

Gene set knowledge discovery with Enrichr

.

Curr Protoc

.

2021

;

1

(

3

):

e90

.

18.

Draper

JE

,

Sroczynska

P

,

Leong

HS

, et al.

Mouse RUNX1C regulates premegakaryocytic/erythroid output and maintains survival of megakaryocyte progenitors

.

Blood

.

2017

;

130

(

3

):

271

-

284

.

19.

Morita

K

,

Suzuki

K

,

Maeda

S

, et al.

Genetic regulation of the RUNX transcription factor family has antitumor effects

.

J Clin Invest

.

2017

;

127

(

7

):

2815

-

2828

.

20.

Bluteau

D

,

Glembotsky

AC

,

Raimbault

A

, et al.

Dysmegakaryopoiesis of FPD/AML pedigrees with constitutional RUNX1 mutations is linked to myosin II deregulated expression

.

Blood

.

2012

;

120

(

13

):

2708

-

2718

.

21.

Ichikawa

M

,

Asai

T

,

Saito

T

, et al.

AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis

.

Nat Med

.

2004

;

10

(

3

):

299

-

304

.

22.

Wang

L

,

Huang

G

,

Zhao

X

, et al.

Post-translational modifications of Runx1 regulate its activity in the cell

.

Blood Cells Mol Dis

.

2009

;

43

(

1

):

30

-

34

.

23.

Zhang

Y

,

Biggs

JR

,

Kraft

AS

.

Phorbol ester treatment of K562 cells regulates the transcriptional activity of AML1c through phosphorylation

.

J Biol Chem

.

2004

;

279

(

51

):

53116

-

53125

.

24.

Long

MW

,

Heffner

CH

,

Williams

JL

,

Peters

C

,

Prochownik

EV

.

Regulation of megakaryocyte phenotype in human erythroleukemia cells

.

J Clin Invest

.

1990

;

85

(

4

):

1072

-

1084

.

25.

Martin

P

,

Papayannopoulou

T

.

HEL cells: a new human erythroleukemia cell line with spontaneous and induced globin expression

.

Science

.

1982

;

216

(

4551

):

1233

-

1235

.

26.

Murate

T

,

Saga

S

,

Hotta

T

, et al.

The close relationship between DNA replication and the selection of differentiation lineages of human erythroleukemia cell lines K562, HEL, and TF1 into either erythroid or megakaryocytic lineages

.

Exp Cell Res

.

1993

;

208

(

1

):

35

-

43

.

27.

Papayannopoulou

T

,

Nakamoto

B

,

Kurachi

S

,

Nelson

R

.

Analysis of the erythroid phenotype of HEL cells: clonal variation and the effect of inducers

.

Blood

.

1987

;

70

(

6

):

1764

-

1772

.

28.

Koh

CP

,

Wang

CQ

,

Ng

CEL

, et al.

RUNX1 meets MLL: epigenetic regulation of hematopoiesis by two leukemia genes

.

Leukemia

.

2013

;

27

(

9

):

1793

-

1802

.

29.

Bailey

TL

.

STREME: accurate and versatile sequence motif discovery

.

Bioinformatics

.

2021

;

37

(

18

):

2834

-

2840

.

30.

Elagib

KE

,

Racke

FK

,

Mogass

M

,

Khetawat

R

,

Delehanty

LL

,

Goldfarb

AN

.

RUNX1 and GATA-1 coexpression and cooperation in megakaryocytic differentiation

.

Blood

.

2003

;

101

(

11

):

4333

-

4341

.

31.

Shrivastava

T

,

Mino

K

,

Babayeva

ND

,

Baranovskaya

OI

,

Rizzino

A

,

Tahirov

TH

.

Structural basis of Ets1 activation by Runx1

.

Leukemia

.

2014

;

28

(

10

):

2040

-

2048

.

32.

Zheng

R

,

Wan

C

,

Mei

S

, et al.

Cistrome Data Browser: expanded datasets and new tools for gene regulatory analysis

.

Nucleic Acids Res

.

2019

;

47

(

D1

):

D729

-

D735

.

33.

Tijssen

MR

,

Cvejic

A

,

Joshi

A

, et al.

Genome-wide analysis of simultaneous GATA1/2, RUNX1, FLI1, and SCL binding in megakaryocytes identifies hematopoietic regulators

.

Dev Cell

.

2011

;

20

(

5

):

597

-

609

.

34.

Wilson

NK

,

Foster

SD

,

Wang

X

, et al.

Combinatorial transcriptional control in blood stem/progenitor cells: genome-wide analysis of ten major transcriptional regulators

.

Cell Stem Cell

.

2010

;

7

(

4

):

532

-

544

.

35.

Pantano

L

.

DEGreport: Report of DEG Analysis. R package version. 2023;1.36.0

. Accessed 31 March 2023. http://lpantano.github.io/DEGreport/.

36.

Fujiki

H

,

Kimura

T

,

Minamiguchi

H

, et al.

Role of human interleukin-9 as a megakaryocyte potentiator in culture

.

Exp Hematol

.

2002

;

30

(

12

):

1373

-

1380

.

37.

Xu

XR

,

Carrim

N

,

Neves

MAD

, et al.

Platelets and platelet adhesion molecules: novel mechanisms of thrombosis and anti-thrombotic therapies

.

Thromb J

.

2016

;

14

(

suppl 1

):

29

.

38.

Zou

S

,

Teixeira

AM

,

Yin

M

, et al.

Leukaemia-associated Rho guanine nucleotide exchange factor (LARG) plays an agonist specific role in platelet function through RhoA activation

.

Thromb Haemost

.

2016

;

116

(

3

):

506

-

516

.

39.

Ji

M

,

Li

H

,

Suh

HC

,

Klarmann

KD

,

Yokota

Y

,

Keller

JR

.

Id2 intrinsically regulates lymphoid and erythroid development via interaction with different target proteins

.

Blood

.

2008

;

112

(

4

):

1068

-

1077

.

40.

Uoshima

N

,

Ozawa

M

,

Kimura

S

, et al.

Changes in c-Kit expression and effects of SCF during differentiation of human erythroid progenitor cells

.

Br J Haematol

.

1995

;

91

(

1

):

30

-

36

.

41.

Love

MI

,

Huber

W

,

Anders

S

.

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

.

Genome Biol

.

2014

;

15

(

12

):

550

.

42.

Tanaka

T

,

Kurokawa

M

,

Ueki

K

, et al.

The extracellular signal-regulated kinase pathway phosphorylates AML1, an acute myeloid leukemia gene product, and potentially regulates its transactivation ability

.

Mol Cell Biol

.

1996

;

16

(

7

):

3967

-

3979

.

43.

Wang

S

,

Zhang

Y

,

Soosairajah

J

,

Kraft

AS

.

Regulation of RUNX1/AML1 during the G2/M transition

.

Leuk Res

.

2007

;

31

(

6

):

839

-

851

.

44.

Wee

HJ

,

Voon

DC

,

Bae

SC

,

Ito

Y

.

PEBP2-beta/CBF-beta-dependent phosphorylation of RUNX1 and p300 by HIPK2: implications for leukemogenesis

.

Blood

.

2008

;

112

(

9

):

3777

-

3787

.

45.

Johnson

JL

,

Yaron

TM

,

Huntsman

EM

, et al.

An atlas of substrate specificities for the human serine/threonine kinome

.

Nature

.

2023

;

613

(

7945

):

759

-

766

.

46.

Elagib

KE

,

Mihaylov

IS

,

Delehanty

LL

, et al.

Cross-talk of GATA-1 and P-TEFb in megakaryocyte differentiation

.

Blood

.

2008

;

112

(

13

):

4884

-

4894

.

47.

Qing

Y

,

Wang

X

,

Wang

H

, et al.

Pharmacologic targeting of the P-TEFb complex as a therapeutic strategy for chronic myeloid leukemia

.

Cell Commun Signal

.

2021

;

19

(

1

):

83

.

48.

Ni

Z

,

Schwartz

BE

,

Werner

J

,

Suarez

J-R

,

Lis

JT

.

Coordination of transcription, RNA processing, and surveillance by P-TEFb kinase on heat shock genes

.

Mol Cell

.

2004

;

13

(

1

):

55

-

65

.

49.

Yoshimi

M

,

Goyama

S

,

Kawazu

M

, et al.

Multiple phosphorylation sites are important for RUNX1 activity in early hematopoiesis and T-cell differentiation

.

Eur J Immunol

.

2012

;

42

(

4

):

1044

-

1050

.

50.

Starck

J

,

Cohet

N

,

Gonnet

C

, et al.

Functional cross-antagonism between transcription factors FLI-1 and EKLF

.

Mol Cell Biol

.

2003

;

23

(

4

):

1390

-

1402

.

51.

Pencovich

N

,

Jaschek

R

,

Tanay

A

,

Groner

Y

.

Dynamic combinatorial interactions of RUNX1 and cooperating partners regulates megakaryocytic differentiation in cell line models

.

Blood

.

2011

;

117

(

1

):

e1

-

e14

.

52.

Bacon

CW

,

D'Orso

I

.

CDK9: a signaling hub for transcriptional control

.

Transcription

.

2019

;

10

(

2

):

57

-

75

.

53.

Jiang

H

,

Zhang

F

,

Kurosu

T

,

Peterlin

BM

.

Runx1 binds positive transcription elongation factor b and represses transcriptional elongation by RNA polymerase II: possible mechanism of CD4 silencing

.

Mol Cell Biol

.

2005

;

25

(

24

):

10675

-

10683

.

54.

Guo

H

,

Friedman

AD

.

Phosphorylation of RUNX1 by cyclin-dependent kinase reduces direct interaction with HDAC1 and HDAC3

.

J Biol Chem

.

2011

;

286

(

1

):

208

-

215

.